Medline Prices Secondary Offering of 75 Million Shares
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy MDLN?
Source: Newsfilter
- Secondary Offering Size: Medline Inc. announced a secondary offering of 75 million shares of Class A common stock priced at $41.00 per share, indicating the company's active engagement in capital markets, even though it will not sell any of its own shares in this offering.
- Underwriter Lineup: The offering is being coordinated by top investment banks including Goldman Sachs, Morgan Stanley, and BofA Securities, reflecting strong market confidence in the transaction, and the diversity of underwriters may enhance the likelihood of a successful offering.
- Additional Purchase Option: The selling stockholders have granted underwriters a 30-day option to purchase an additional 11.25 million shares, which could further increase liquidity and investor interest in the stock.
- Expected Transaction Closure: The offering is expected to close on March 10, 2026, subject to customary closing conditions, and a successful completion will provide liquidity for the selling stockholders while reflecting ongoing demand for medical supply chain solutions in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MDLN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MDLN
Wall Street analysts forecast MDLN stock price to rise
14 Analyst Rating
13 Buy
1 Hold
0 Sell
Strong Buy
Current: 43.410
Low
42.00
Averages
47.92
High
52.00
Current: 43.410
Low
42.00
Averages
47.92
High
52.00
About MDLN
Medline Inc. is a provider of medical-surgical products and supply chain solutions serving all points of care. The Company delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. It operates through two segments: Medline Brand and Supply Chain Solutions. These segments offer approximately 335,000 medical-surgical products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Its Medline Brand products are organized into three product categories: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands and also provides tailored logistics and supply chain optimization services to domestic and international consumers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Medline Closes Secondary Offering of 86.25 Million Shares
- Successful Secondary Offering: Medline Inc. has completed a secondary offering of 86.25 million shares of Class A common stock at a public price of $41.00 per share, indicating sustained market demand despite the company not participating directly in the sale.
- Key Shareholder Participation: The offering involved selling stockholders affiliated with Blackstone, Carlyle Group, and Hellman & Friedman, suggesting these investors maintain an optimistic outlook on Medline's long-term prospects, potentially boosting market confidence.
- Strong Underwriter Lineup: Top investment banks including Goldman Sachs, Morgan Stanley, and BofA Securities acted as global coordinators, reflecting market recognition of Medline and laying a foundation for future financing activities.
- Compliance Statement: The offering adheres to SEC registration statements, ensuring compliance and reducing legal risks, which further enhances investor trust in Medline.
See More
Medline Announces 2025 Distribution Center Awards
- Annual Awards Ceremony: Medline awarded its 2025 Distribution Center of the Year and SAFE Awards to top-performing facilities in the U.S., highlighting the company's commitment to operational excellence across safety, service, and quality metrics.
- Award Distribution: Rialto, California, and Katy, Texas, received the Distribution Center of the Year and SAFE Awards respectively, while Richmond, Virginia, achieved the rare distinction of winning both awards, showcasing its outstanding safety and service performance.
- Supply Chain Efficiency: Medline's network of 45 distribution centers enables next-day delivery to 95% of U.S. customers, reflecting the company's effective management of healthcare supply chains and the dedication of its team members.
- Safety Culture Development: The Richmond center's team emphasizes that safety is not just a program but a core part of their culture, ensuring employees work in a safe environment, which enhances overall service quality and employee satisfaction.
See More
Medline Announces 2025 Distribution Center Awards Recognizing Excellence
- Distribution Center Awards: Medline has awarded its 2025 Distribution Center of the Year awards to facilities excelling in safety, service, quality, cost, and personnel, reflecting the company's ongoing commitment to operational excellence.
- Safety Awareness Recognition: The 2025 SAFE Award recipients include Katy, Texas; Mebane, North Carolina; Richmond, Virginia; and Lincolnton, North Carolina, highlighting Medline's outstanding performance in safety management.
- Next-Day Delivery Capability: Medline achieves a 95% next-day delivery rate for U.S. customers through its network of 45 distribution centers, showcasing its robust supply chain capabilities and the dedication of its team to ensure timely delivery of medical products.
- Cultural Commitment: The Richmond distribution center's dual award recognition underscores the team's commitment to safety culture and mutual support, enhancing employee satisfaction and safety awareness in the workplace.
See More
Medline Announces Secondary Offering of 75 Million Shares
- Offering Size: Medline announced a secondary public offering of 75 million shares priced at $41 each, valuing the transaction at approximately $3.08 billion, providing liquidity for existing investors while the company itself is not directly involved.
- Key Investors: The shares are being sold by existing investors linked to Blackstone, The Carlyle Group, Hellman & Friedman, and a subsidiary of Abu Dhabi Investment Authority, indicating strong confidence from these institutional players in the market.
- Underwriter Option: The underwriters have a 30-day option to purchase up to an additional 11.25 million shares, which could further influence market supply and demand dynamics, potentially increasing investor participation.
- Market Reaction: Following the announcement, Medline's stock dipped slightly to $42.75 in pre-market trading on Thursday, reflecting a cautious market sentiment regarding the offering, which may impact short-term stock performance.
See More
Medline Prices Secondary Offering of 75 Million Shares
- Secondary Offering Size: Medline Inc. announced a secondary offering of 75 million shares of Class A common stock priced at $41.00 per share, indicating the company's active engagement in capital markets, even though it will not sell any of its own shares in this offering.
- Underwriter Lineup: The offering is being coordinated by top investment banks including Goldman Sachs, Morgan Stanley, and BofA Securities, reflecting strong market confidence in the transaction, and the diversity of underwriters may enhance the likelihood of a successful offering.
- Additional Purchase Option: The selling stockholders have granted underwriters a 30-day option to purchase an additional 11.25 million shares, which could further increase liquidity and investor interest in the stock.
- Expected Transaction Closure: The offering is expected to close on March 10, 2026, subject to customary closing conditions, and a successful completion will provide liquidity for the selling stockholders while reflecting ongoing demand for medical supply chain solutions in the market.
See More
Medline Inc. Plans to Offer 75 Million Shares
- Offering Size: Medline Inc. is set to offer 75 million shares of its Class A common stock, aiming to raise $3.4 billion, with pricing expected post-market on Wednesday, indicating sustained market demand for medical supply chains.
- Key Shareholder Participation: Major shareholders including Blackstone, Carlyle Group, Hellman and Friedman LLC, and Abu Dhabi Investment Authority are each offering shares, with Blackstone, Carlyle, and Hellman each contributing 23.3 million shares and ADIA 5.1 million shares, reflecting investor confidence in Medline's future growth.
- Underwriter Lineup: Top investment banks such as Morgan Stanley, Bank of America, JPMorgan Chase, and Goldman Sachs are involved in the offering, showcasing strong market interest in Medline and providing investors with diversified investment options.
- Company Background: Medline is the largest provider of medical-surgical products and supply chain solutions globally, operating 30 manufacturing facilities and 70 distribution centers with a workforce of 45,000; despite a recent 4.6% stock decline, the stock has risen nearly 7% year-to-date.
See More
Medline Closes Secondary Offering of 86.25 Million Shares
- Successful Secondary Offering: Medline Inc. has completed a secondary offering of 86.25 million shares of Class A common stock at a public price of $41.00 per share, indicating sustained market demand despite the company not participating directly in the sale.
- Key Shareholder Participation: The offering involved selling stockholders affiliated with Blackstone, Carlyle Group, and Hellman & Friedman, suggesting these investors maintain an optimistic outlook on Medline's long-term prospects, potentially boosting market confidence.
- Strong Underwriter Lineup: Top investment banks including Goldman Sachs, Morgan Stanley, and BofA Securities acted as global coordinators, reflecting market recognition of Medline and laying a foundation for future financing activities.
- Compliance Statement: The offering adheres to SEC registration statements, ensuring compliance and reducing legal risks, which further enhances investor trust in Medline.
See More
Medline Announces 2025 Distribution Center Awards
- Annual Awards Ceremony: Medline awarded its 2025 Distribution Center of the Year and SAFE Awards to top-performing facilities in the U.S., highlighting the company's commitment to operational excellence across safety, service, and quality metrics.
- Award Distribution: Rialto, California, and Katy, Texas, received the Distribution Center of the Year and SAFE Awards respectively, while Richmond, Virginia, achieved the rare distinction of winning both awards, showcasing its outstanding safety and service performance.
- Supply Chain Efficiency: Medline's network of 45 distribution centers enables next-day delivery to 95% of U.S. customers, reflecting the company's effective management of healthcare supply chains and the dedication of its team members.
- Safety Culture Development: The Richmond center's team emphasizes that safety is not just a program but a core part of their culture, ensuring employees work in a safe environment, which enhances overall service quality and employee satisfaction.
See More
Medline Announces 2025 Distribution Center Awards Recognizing Excellence
- Distribution Center Awards: Medline has awarded its 2025 Distribution Center of the Year awards to facilities excelling in safety, service, quality, cost, and personnel, reflecting the company's ongoing commitment to operational excellence.
- Safety Awareness Recognition: The 2025 SAFE Award recipients include Katy, Texas; Mebane, North Carolina; Richmond, Virginia; and Lincolnton, North Carolina, highlighting Medline's outstanding performance in safety management.
- Next-Day Delivery Capability: Medline achieves a 95% next-day delivery rate for U.S. customers through its network of 45 distribution centers, showcasing its robust supply chain capabilities and the dedication of its team to ensure timely delivery of medical products.
- Cultural Commitment: The Richmond distribution center's dual award recognition underscores the team's commitment to safety culture and mutual support, enhancing employee satisfaction and safety awareness in the workplace.
See More
Medline Announces Secondary Offering of 75 Million Shares
- Offering Size: Medline announced a secondary public offering of 75 million shares priced at $41 each, valuing the transaction at approximately $3.08 billion, providing liquidity for existing investors while the company itself is not directly involved.
- Key Investors: The shares are being sold by existing investors linked to Blackstone, The Carlyle Group, Hellman & Friedman, and a subsidiary of Abu Dhabi Investment Authority, indicating strong confidence from these institutional players in the market.
- Underwriter Option: The underwriters have a 30-day option to purchase up to an additional 11.25 million shares, which could further influence market supply and demand dynamics, potentially increasing investor participation.
- Market Reaction: Following the announcement, Medline's stock dipped slightly to $42.75 in pre-market trading on Thursday, reflecting a cautious market sentiment regarding the offering, which may impact short-term stock performance.
See More
Medline Prices Secondary Offering of 75 Million Shares
- Secondary Offering Size: Medline Inc. announced a secondary offering of 75 million shares of Class A common stock priced at $41.00 per share, indicating the company's active engagement in capital markets, even though it will not sell any of its own shares in this offering.
- Underwriter Lineup: The offering is being coordinated by top investment banks including Goldman Sachs, Morgan Stanley, and BofA Securities, reflecting strong market confidence in the transaction, and the diversity of underwriters may enhance the likelihood of a successful offering.
- Additional Purchase Option: The selling stockholders have granted underwriters a 30-day option to purchase an additional 11.25 million shares, which could further increase liquidity and investor interest in the stock.
- Expected Transaction Closure: The offering is expected to close on March 10, 2026, subject to customary closing conditions, and a successful completion will provide liquidity for the selling stockholders while reflecting ongoing demand for medical supply chain solutions in the market.
See More
Medline Inc. Plans to Offer 75 Million Shares
- Offering Size: Medline Inc. is set to offer 75 million shares of its Class A common stock, aiming to raise $3.4 billion, with pricing expected post-market on Wednesday, indicating sustained market demand for medical supply chains.
- Key Shareholder Participation: Major shareholders including Blackstone, Carlyle Group, Hellman and Friedman LLC, and Abu Dhabi Investment Authority are each offering shares, with Blackstone, Carlyle, and Hellman each contributing 23.3 million shares and ADIA 5.1 million shares, reflecting investor confidence in Medline's future growth.
- Underwriter Lineup: Top investment banks such as Morgan Stanley, Bank of America, JPMorgan Chase, and Goldman Sachs are involved in the offering, showcasing strong market interest in Medline and providing investors with diversified investment options.
- Company Background: Medline is the largest provider of medical-surgical products and supply chain solutions globally, operating 30 manufacturing facilities and 70 distribution centers with a workforce of 45,000; despite a recent 4.6% stock decline, the stock has risen nearly 7% year-to-date.
See More
